PV Bulletin

Voluntary Data Submission Pilot to Advance Innovative Alternatives to Animal Testing

The European Medicines Agency (EMA) has launched a voluntary data submission pilot for developers to present New Approach Methodologies (NAMs) data.

Primary source: View

PV Impact Brief

MonitoringConfidence: high

What changed

A voluntary data submission pilot has been initiated, enabling stakeholders to submit NAMs data for consideration independent of existing regulatory procedures.

Why it matters

This initiative promotes the use of innovative testing methodologies, potentially leading to reduced reliance on animal testing and more efficient regulatory decision-making.

Action needed

Stakeholders can submit NAMs data by completing the prescribed application form, available until Q3 2027.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Country Compliance
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 1, 2026

Full briefing

Practical implication

Stakeholders can submit NAMs data by completing the prescribed application form, available until Q3 2027.

The EMA's new pilot allows stakeholders to submit NAM data for tailored feedback, aiming to facilitate innovative alternatives to traditional animal testing.

What changed: A voluntary data submission pilot has been initiated, enabling stakeholders to submit NAMs data for consideration independent of existing regulatory procedures.

Why it matters: This initiative promotes the use of innovative testing methodologies, potentially leading to reduced reliance on animal testing and more efficient regulatory decision-making.

Practical implication: Stakeholders can submit NAMs data by completing the prescribed application form, available until Q3 2027.

View original source

  • Source: EMA - What's new
  • Published at source: 2026-09-01T13:48:00.000Z
  • Discovered by monitor: 2026-09-02T21:45:26.922Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Urgent Withdrawal of Reusable da Vinci S and Si Instruments Due to Cable Degradation

Urgency: High

Healthcare facilities must isolate the affected instruments and notify Intuitive Surgical for returns while preparing for potential delays in surgical procedures due to instrument replacements.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Latest
Read impact briefarrow_forward
publicANSM · France · Updated Sep 7, 2026Translated From French

Injunction No. 2026-DM-031-INJ Regarding Ortho Partner Establishment in Montreuil

Urgency: High

Establish compliant storage conditions for medical devices and set up a non-conformity management system within 3 months.

Inspection ReadinessRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward